UTHR
United Therapeutics Corporation · Healthcare · Biotechnology
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q2 2024
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 157 | +4 | 27.98M | $15.17B | +8 | −5 |
| Q1 2026 | 157 | -1 | 29.64M | $17.54B | +5 | −7 |
| Q4 2025 | 157 | +1 | 32.29M | $15.72B | +2 | n/a |
| Q3 2025 | 21 | 0 | 20.11M | $8.43B | +1 | −2 |
| Q2 2025 | 19 | 0 | 20.17M | $5.79B | n/a | n/a |
| Q1 2025 | 16 | +1 | 10.14M | $3.12B | +1 | n/a |
| Q4 2024 | 15 | 0 | 10.52M | $3.71B | +1 | −1 |
| Q3 2024 | 14 | 0 | 8.99M | $3.22B | n/a | n/a |
| Q2 2024 | 14 | n/a | 8.17M | $2.60B | n/a | n/a |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 3.29M | n/a | $1.05B | 0.2% | n/c | 1 | SEC ↗ ×9 |
| 2 | Renaissance Technologies ✦ | 2.17M | n/a | $692.75M | 1.2% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (pasif) | 1.05M | n/a | $333.57M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 4 | AQR Capital Management ✦ | 719.51K | n/a | $229.20M | 0.4% | n/c | 1 | SEC ↗ ×3 |
| 5 | Arrowstreet Capital ✦ | 438.68K | n/a | $139.74M | 0.1% | n/c | 1 | SEC ↗ |
| 6 | T. Rowe Price ✦ | 234.92K | n/a | $74.83M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 103.03K | n/a | $32.82M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | Gotham Asset Management ✦ | 47.59K | n/a | $15.16M | 0.2% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 42.02K | n/a | $13.39M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 10 | Norges Bank ✦ (pasif) | 38.93K | n/a | $12.40M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Marshall Wace ✦ | 20.11K | n/a | $6.40M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | Bridgewater Associates ✦ | 12.75K | n/a | $4.06M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Fisher Asset Management ✦ | 5.16K | n/a | $1.64M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Two Sigma Investments ✦ | 1.90K | n/a | $605,245 | 0.0% | n/c | 1 | SEC ↗ |
"Their weight" = porsi posisi dari nilai ekuitas 13F yang dilaporkan manajer tersebut: ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Tidak ada pembeli terlacak baru kuartal ini. |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 844 pemegang, 41.22M saham, $23.10B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang sekuritas ini yang dilacak: jumlah kepemilikan bersama, bukan hubungan fundamental.
Pembelian di pasar terbuka (P)
Tidak ada pembelian insider di pasar terbuka dalam jendela cakupan kami.
Penjualan di pasar terbuka (S)
Officer, Director · 200 lbr · $110,143
Officer, Director · 2.17K lbr · $1.19M
Officer, Director · 281 lbr · $151,874
Officer · 268 lbr · $145,160
Officer, Director · 456 lbr · $247,462
Officer, Director · 601 lbr · $328,713
Officer, Director · 371 lbr · $201,599
Officer · 1.98K lbr · $1.08M
Officer · 791 lbr · $430,975
Officer, Director · 825 lbr · $450,347
Penghargaan, eksekusi, dan pemotongan pajak tidak pernah dihitung sebagai pembelian atau penjualan di sini. Metodologi